| Announce Date | 11/05/2025 |
| EPS Normalized Actual | $0.02 In Line |
| EPS GAAP Actual | $0.02 In Line |
| Revenue Actual | $0.110252B |
| Revenue Surprise | Beat by $110.252M |
| Announce Date | 03/30/2026 (Pre-Market) |
| EPS Normalized Estimate | $-0.00785 |
| EPS GAAP Estimate | $-0.00785 |
| Revenue Estimate | $0.0955596B |
| Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
|---|---|---|---|---|---|
| Dec 2027 | 0.1532 | 9.79 | 0.14699 | 0.15679 | 2 |
| Dec 2026 | 0 | INF | 0 | 0 | 0 |
| Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
|---|---|---|---|---|---|
| FQ3 2025 (Sep 2025) | -0.0056 | -0.0203 | 0.110252B | -274210.67% | -3.1M |
| FQ2 2025 (Jun 2025) | -0.01 | -0.04325 | 0.108936B | 3.22% | -10.4M |
| FQ1 2025 (Mar 2025) | -0.03 | -0.04375 | 93.884B | -3.68% | 93780.95M |
| FQ4 2024 (Dec 2024) | 3.63 | 3.61 | 0B | -INF% | -117.38M |
| FQ3 2024 (Sep 2024) | 103.51 | 103.505 | 302.433B | 99.96% | 302325.62M |
| FQ2 2024 (Jun 2024) | 0.014 | -1.32859 | 0.105426B | -4.51% | -114.94M |
| FQ1 2020 (Mar 2020) | 0 | 0 | 0.045882B | 100% | 45.88M |
| FQ2 2020 (Jun 2020) | 0 | 0 | 0.042198B | 100% | 42.2M |
FQ4 Announce Date
03/30/2026 (Pre-Market)
Consensus EPS Estimates
-0.00785
Consensus Revenue Estimates
0.0955596B
| Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2026 (Dec 2026) | 0.0471 | -- | 0.04605714 | 0.0477341 | 1 |
| FQ3 2026 (Sep 2026) | 0.01475 | 137.97 | 0.01466471 | 0.0148881 | 1 |
| FQ2 2026 (Jun 2026) | 0.0128 | 178.13 | 0.01272598 | 0.01291984 | 1 |
| FQ1 2026 (Mar 2026) | -0.00785 | -282.17 | -0.0079235 | -0.00780461 | 1 |
| Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2026 (Dec 2026) | 0.12B | -- | 0.12B | 0.12B | 2 |
| FQ3 2026 (Sep 2026) | 0.11B | -4.69 | 0.1B | 0.11B | 1 |
| FQ2 2026 (Jun 2026) | 0.11B | -2.42 | 0.11B | 0.11B | 1 |
| FQ1 2026 (Mar 2026) | 0.1B | -98146.54 | 0.1B | 0.1B | 1 |
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
EPS # of Beats
2
EPS # of Misses
4
EPS # of in-lines
2
Revenue # of Beats
4
Revenue # of Misses
4
Revenue # of in-lines
0
| Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ3 2025 (Sep 2025) | 0.0147 | -0.0056 | -0.0203 | 362.5% |
| FQ2 2025 (Jun 2025) | 0.03325 | -0.01 | -0.04325 | 432.5% |
| FQ1 2025 (Mar 2025) | 0.01375 | -0.03 | -0.04375 | 145.83% |
| FQ4 2024 (Dec 2024) | 0.02 | 3.63 | 3.61 | 99.45% |
| FQ3 2024 (Sep 2024) | 0.005 | 103.51 | 103.505 | 100% |
| FQ2 2024 (Jun 2024) | 1.34259 | 0.014 | -1.32859 | -9489.93% |
| FQ1 2020 (Mar 2020) | 0 | 0 | NAN% | |
| FQ2 2020 (Jun 2020) | 0 | 0 | NAN% |
| Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ3 2025 (Sep 2025) | $0.11B | $0.11B | $-3.1M | -2.82% |
| FQ2 2025 (Jun 2025) | $0.12B | $0.11B | $-10.4M | -9.55% |
| FQ1 2025 (Mar 2025) | $0.1B | $93.88B | $93780.95M | 99.89% |
| FQ4 2024 (Dec 2024) | $0.12B | $0B | $-117.38M | -INF% |
| FQ3 2024 (Sep 2024) | $0.11B | $302.43B | $302325.62M | 99.96% |
| FQ2 2024 (Jun 2024) | $0.22B | $0.11B | $-114.94M | -109.03% |
| FQ1 2020 (Mar 2020) | $0B | $0.05B | $45.88M | 100% |
| FQ2 2020 (Jun 2020) | $0B | $0.04B | $42.2M | 100% |